Mytrex Health Technologies, Inc. (4431.TWO)
TWD 20.4
(-1.92%)
TWD 20.4
(-1.92%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -4.25 Million | 72.47 Million | 13.28 Million | 440.76 Million | 59.91 Million |
| Net Income | -57.18 Million | -61.85 Million | -13.59 Million | 441.15 Million | 9.31 Million |
| Depreciation & Amortization | 96.98 Million | 106.5 Million | 50.6 Million | 27.45 Million | 20.58 Million |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | - | -2.9 Million | 31.21 Million | - |
| Change in working capital | -40.33 Million | -1.13 Million | 60.79 Million | -54.93 Million | 54.13 Million |
| Other non-cash items | 3.44 Million | 4.09 Million | 895 Thousand | 1.27 Million | -24.11 Million |
| Investing Cash Flow | -268.29 Million | -87.91 Million | -31.06 Million | -198.36 Million | -6.65 Million |
| Investments in PPE | -25.01 Million | -43.31 Million | -30.33 Million | -189.26 Million | -9.66 Million |
| Acquisitions | -230 Million | 2 Million | -11 Million | -652 Thousand | - |
| Investment purchases | -11.5 Million | -65.59 Million | -39.63 Million | -4.73 Million | - |
| Sales/Maturities of investments | 10.59 Million | 11.34 Million | 57.58 Million | - | - |
| Other Investing Activities | -4.16 Million | -1.94 Million | -10.08 Million | -4.46 Million | 3 Million |
| Financing Cash Flow | 5.41 Million | -59.83 Million | -241.28 Million | 345.78 Million | -24.75 Million |
| Debt repayment | -50.51 Million | -9.95 Million | -109.03 Million | -88.05 Million | -4.83 Million |
| Dividends payments | - | - | -121.78 Million | -4.12 Million | -5.03 Million |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | - | - | - | 264 Million | - |
| Other Financing Activities | 260 Thousand | -16.81 Million | -109.03 Million | 2.69 Million | -3000.00 |
| Accounts receivables | -43.53 Million | 18.51 Million | 45.13 Million | -27.05 Million | 24.72 Million |
| Accounts payables | 70.99 Million | - | - | - | - |
| Inventory | -18.64 Million | 3.46 Million | 41.96 Million | -62.59 Million | 22.69 Million |
| Other working capital | -50.21 Million | -13.42 Million | -20.47 Million | 37.43 Million | 6.71 Million |
| Cash at beginning of period | 486.52 Million | 559.72 Million | 735.28 Million | 150.2 Million | 122.64 Million |
| Cash at end of period | 218.65 Million | 486.52 Million | 471.2 Million | 735.28 Million | 150.2 Million |
| Capital Expenditure | -25.01 Million | -43.31 Million | -30.33 Million | -189.26 Million | -9.66 Million |
| Effect of forex changes on cash | -736 Thousand | 2.07 Million | -5.01 Million | -3.1 Million | -940 Thousand |
| Net cash flow / Change in cash | -267.87 Million | -73.19 Million | -264.07 Million | 585.08 Million | 27.55 Million |
| Free Cash Flow | -29.27 Million | 29.16 Million | -17.04 Million | 251.49 Million | 50.25 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -3.86 Million | -3.86 Million | -17.57 Million | -57.18 Million | -17.57 Million | -10.53 Million |
| Depreciation & Amortization | 24.85 Million | 25.05 Million | 22.05 Million | 96.98 Million | 22.05 Million | 23.58 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -44.35 Million | -48.65 Million | -20.29 Million | -40.33 Million | -20.29 Million | -35.9 Million |
| Other non-cash items | 55.14 Million | 59.23 Million | 22.88 Million | 3.44 Million | 22.88 Million | 13.64 Million |
| Investing Cash Flow | 10.29 Million | 10.29 Million | -6.54 Million | -268.29 Million | -6.54 Million | -127.6 Million |
| Investments in PPE | -3.27 Million | -3.27 Million | -2.7 Million | -25.01 Million | -2.7 Million | -8.17 Million |
| Acquisitions | 52.08 Million | - | - | -230 Million | - | -115 Million |
| Investment purchases | - | - | - | -11.5 Million | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 13.56 Million | 13.56 Million | -3.83 Million | -4.16 Million | -3.83 Million | -4.42 Million |
| Financing Cash Flow | -168 Thousand | -168 Thousand | -6.68 Million | 5.41 Million | -6.68 Million | 9.39 Million |
| Debt repayment | -42.8 Million | - | - | -50.51 Million | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -168 Thousand | -168 Thousand | -6.68 Million | 260 Thousand | -6.68 Million | 9.39 Million |
| Accounts receivables | -3.66 Million | -3.66 Million | -24.58 Million | -43.53 Million | -24.58 Million | 2.81 Million |
| Accounts payables | 132.04 Million | - | - | - | - | - |
| Inventory | -4.8 Million | -4.8 Million | -710.5 Thousand | -18.64 Million | -710.5 Thousand | -8.61 Million |
| Other working capital | -35.89 Million | -40.18 Million | 5 Million | -50.21 Million | 5 Million | -30.1 Million |
| Cash at beginning of period | 240.74 Million | - | - | 486.52 Million | - | - |
| Cash at end of period | 42.4 Million | 42.4 Million | -7.29 Million | 218.65 Million | -7.29 Million | -126.64 Million |
| Capital Expenditure | -3.27 Million | -3.27 Million | -2.7 Million | -25.01 Million | -2.7 Million | -8.17 Million |
| Effect of forex changes on cash | 512 Thousand | 512 Thousand | -1.13 Million | -736 Thousand | -1.13 Million | 769 Thousand |
| Net cash flow / Change in cash | -198.34 Million | 42.4 Million | -7.29 Million | -267.87 Million | -7.29 Million | -126.64 Million |
| Free Cash Flow | 28.49 Million | 28.49 Million | 4.36 Million | -29.27 Million | 4.36 Million | -17.38 Million |
PARAUCO
ORC
6693
DKFT
3653
MRCHF